Renaissance Technologies »

Cardiol Therapeutics Inc- foreign shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Cardiol Therapeutics Inc- foreign (CRDL) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Cardiol Therapeutics Inc- foreign

Tip: Access up to 7 years of quarterly data

All positions including Cardiol Therapeutics Inc- foreign held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiol Therapeutics Inc- foreign by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2026-03-31 $310k 230k 1.35
2023-03-31 $5.0k 10k 0.50
2021-12-31 $171k 93k 1.84
2021-09-30 $598k 145k 4.13

More positions owned by Renaissance Technologies

United Therapeutics Corporation (UTHR)
Palantir Technologies Cl A (PLTR)
Apple (AAPL)
Kinross Gold Corp (KGC)
Micron Technology (MU)
Verisign (VRSN)
Exelixis (EXEL)
Franco-Nevada Corporation (FNV)
Sandisk Corp (SNDK)
NVIDIA Corporation (NVDA)
Chevron Corporation (CVX)
Roblox Corp Cl A (RBLX)
Carvana Cl A (CVNA)
Wayfair Cl A (W)
Robinhood Mkts Com Cl A (HOOD)

View all positions for Renaissance Technologies

Top funds holding Cardiol Therapeutics Inc- foreign

MMCAP International Inc. SPC
Tejara Capital
Ikarian Capital
Citadel Advisors
Boothbay Fund Management
Two Sigma Investments
Integrity Alliance
Goldman Sachs Group
Morgan Stanley
Renaissance Technologies
Jane Street
Pvg Asset Management
Summit Financial
Knoll Capital Management
Goodman & Company, Investment Counsel

View all funds holding Cardiol Therapeutics Inc- foreign